+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ambrx Inc - logo

Ambrx is a biopharmaceutical company that produces protein therapeutics which reduce frequency of dosing, and optimizes efficiency and safety. Ambrx, Inc. was founded in 2003 and is based in La Jolla, California. The company collaborates with Mabspace Biosciences for oncology purposes in China and internationally. They develop a range of products such as ADC, long-acting protein product candidates, collaboration product and product candidates, and other early-stage programs.

From
Advanced Gastric Carcinoma - Pipeline Insight, 2024 - Product Thumbnail Image

Advanced Gastric Carcinoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 80 Pages
  • Global
From
From
Ovarian Cancer - Pipeline Review, H1 2020 - Product Thumbnail Image

Ovarian Cancer - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 3802 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • March 2024
  • 1300 Pages
  • Global
From
Cancer Biologics Market Report 2023-2033 - Product Thumbnail Image

Cancer Biologics Market Report 2023-2033

  • Report
  • June 2023
  • 308 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • March 2024
  • 1000 Pages
  • Global
From
Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Metastatic Hormone Refractory Prostate Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Esophageal Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Esophageal Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 1584 Pages
  • Global
From
Nasopharyngeal Cancer - Pipeline Review, H2 2020 - Product Thumbnail Image

Nasopharyngeal Cancer - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 854 Pages
  • Global
From
Licensing Deals in Biotechnology 2019-2024 - Product Thumbnail Image

Licensing Deals in Biotechnology 2019-2024

  • Report
  • March 2024
  • 1100 Pages
  • Global
From
Collaboration Deals in Biotechnology 2019-2024 - Product Thumbnail Image

Collaboration Deals in Biotechnology 2019-2024

  • Report
  • March 2024
  • 1100 Pages
  • Global
From
From
From
Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020 - Product Thumbnail Image

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 2815 Pages
  • Global
From
Loading Indicator